Newsweek and Statista have crunched the data and ranked the top U.S. hospitals for cardiac care. Did your facility make the cut? Newsweek and Statista have crunched the data and ranked the top U.S. hospitals for cardiac care. Did your facility make the cut? | | |
|
The robots are capable of swimming through a patient’s vascular system and removing blood clots. “It’s unbelievable," one Stanford researcher said. "This is a sea-change technology that will drastically improve our ability to help people.” The robots are capable of swimming through a patient’s vascular system and removing blood clots. “It’s unbelievable," one Stanford researcher said. "This is a sea-change technology that will drastically improve our ability to help people.” | | |
|
The EARLY TAVR clinical trial made a significant impact, paving the way for the FDA to approve multiple transcatheter heart valves for the treatment of asymptomatic patients. However, one cardiologist who participated in the trial has some serious concerns with how its findings were presented to the public. The EARLY TAVR clinical trial made a significant impact, paving the way for the FDA to approve multiple transcatheter heart valves for the treatment of asymptomatic patients. However, one cardiologist who participated in the trial has some serious concerns with how its findings were presented to the public. | | |
|
“Just as medicine has its own language, so does business," two surgeons explained in a new editorial. “Just as medicine has its own language, so does business," two surgeons explained in a new editorial. | | |
|
To be exact, the average weight time for a cardiologist appointment in U.S. cities is 32.7 days. This is a 23% increase compared to 2022 and a 74% increase compared to 2004. To be exact, the average weight time for a cardiologist appointment in U.S. cities is 32.7 days. This is a 23% increase compared to 2022 and a 74% increase compared to 2004. | | |
|
Overall, 30-day outcomes were not significantly different for hospitals after being acquired by a private equity firm. However, the study’s authors did identify trends that suggest there may be a drop in the quality of care. Overall, 30-day outcomes were not significantly different for hospitals after being acquired by a private equity firm. However, the study’s authors did identify trends that suggest there may be a drop in the quality of care. | | |
|
The patient, 67, presented with a failing TAVR valve and a leaky mitral valve. She had undergone TAVR four years prior, but premature structural valve degeneration made a full replacement necessary. Surgeons ultimately removed the TAVR valve in addition to replacing her aortic and mitral valves—all with the help of advanced robotics. The patient, 67, presented with a failing TAVR valve and a leaky mitral valve. She had undergone TAVR four years prior, but premature structural valve degeneration made a full replacement necessary. Surgeons ultimately removed the TAVR valve in addition to replacing her aortic and mitral valves—all with the help of advanced robotics. | | |
|
Widaplik, the new polypill from George Medicines, includes telmisartan, amlodipine and indapamide. The FDA's decision comes after positive data were published in both JACC and The Lancet. Widaplik, the new polypill from George Medicines, includes telmisartan, amlodipine and indapamide. The FDA's decision comes after positive data were published in both JACC and The Lancet. | | |
|
Cuffless BP measurements could potentially provide significant value for clinicians and patients alike. It is still too early, however, for these technologies to be used in a clinical setting; too many unanswered questions remain. Cuffless BP measurements could potentially provide significant value for clinicians and patients alike. It is still too early, however, for these technologies to be used in a clinical setting; too many unanswered questions remain. | | |
|
Cardiovascular Associates of America and cardiologist-founded HybridChart are now working together in a move designed to deliver value-based care to heart patients. Cardiovascular Associates of America and cardiologist-founded HybridChart are now working together in a move designed to deliver value-based care to heart patients. | | |
|
